Quote:
|
Originally Posted by Synchro246
I am looking for the risks to the Hepatitis B vaccine. I would like numbers wherever possible and sources please. I do not want anecdotes. If the risk is theoretical please say that in your post. I welcome theory, I just want to know when I'm getting theory and when I'm getting "fact".
|
Here's some info I have collected about this vax, and jftr, my 4th child got the 1st dose at 7.5 months and within a day was having breathing problems and began to lose weight. He gained back the little that he lost, then no more, for almost five months, then gained a pound, another 5 months, another pound. He is now 7 yrs old and tops 32 pounds on the scale. I hate this vax. Anyway, take what info you find useful and toss the rest.
Government-mandated Thalidomide for babies?
http://www.worldnetdaily.com/news/ar...TICLE_ID=16053
What is wrong with this supposedly-safe vaccine that 80% of US babies now receive at birth?
"Ask Martha Durham in Wilmington, Delaware.
Her daughter Eliza became highly agitated with a fever in the hospital immediately after getting the Hepatitis B vaccine at birth.
Ask Debbie Parker in Porterville, California.
Her son Matthew died in her arms after getting the Hepatitis B vaccine and the local Sheriff threatened her with murder charges
Dr. Bonnie Dunbar at Baylor College of Medicine in Houston, Texas.
Her brother has severe, debilitating auto-immune neurological damage after a Hepatitis B vaccination
Ask Dr. Burton A. Waisbren at the Waisbren Clinic in Milwaukee, Wisconsin. He has seen enough cases of central nervous system damage from this vaccine to title a paper "Universal Hepatitis B Vaccination: Is it a Sword of Damocles Hanging Over the Head of the American People?"
Ask me.
My five-week-old daughter Lyla Rose died hours after receiving the Hepatitis B vaccine and the New York City medical examiner refused to even mention her swollen brain or the vaccination in the autopsy report -- telling me "vaccines do a lot of good things for people."
********************************************
COMMENTARY -
Universal Hepatitis B Vaccination: Is it a Sword of Damocles Hanging Over the Head of the American People?
Burton A. Waisbren, MS, MD, FACP, FASID
http://nyvic.org/nyvic/health/hep-b/sword.htm
*************************************************
"We tried vaccinating just high risk groups in the 1980s and we were not successful in reducing the disease," Margolis recalled. By the late 1980s, CDC epidemiologists had learned that it is nearly impossible to vaccinate people after they have joined high-risk groups, such as sexually active adolescents and adults with multiple sexual partners or sexually transmitted diseases, men who have sex with men, and sexual and household contacts of infected persons."
http://home.san.rr.com/via/VACCINE/hepatiti.htmhttp://home.san.rr.com/via/VACCINE/kinsboune.htmhttp://home.san.rr.com/via/
************************************************** *****
From the insert,
"Because vaccination recommendations limited to high-risk individuals have failed to
substantially lower the overall incidence of hepatitis B infection, both the Advisory Committee on Immunization Practices (ACIP) and the Committee on Infectious Diseases of the American Academy of Pediatrics (AAP) have endorsed universal infant immunization as part of a comprehensive strategy for the control of hepatitis B infection.32,50"41
http://www.merck.com/product/usa/pi_.../comvax_pi.pdf
************************************************** ******
If you do a search of ACTUAL incidence, the number is much lower. In fact one year (1996)listed less than 11,000 cases TOTAL, so I don't know where they are pulling that 300,000 number from....out of the air I think.
They claim 200,000 new cases per year yet actual cases reported, (that was on the VIS I was given in 1999)
Hepatitis B Reported Annually: 8,036 (2000)
It was 10,000 + in 1996...
"the view held is that there were 300,000 new acute infections each year"
"Since about 1984, the estimated incidence of acute HBV infection has begun to fall not, it is thought, a result of the initial HBV vaccination programs that targetted high risk groups, but because of changes in high risk behavior among homosexual men."
Hmm, so if "estimated" incidence began to fall, I wonder why they dragged our precious babies into this mess.
"Since 1987, the rate of acute infection has fallen by 50%, perhaps because of the introduction of universal immunization of neonates, vaccination of occupationally exposed persons, refinements in the screening of blood donors, and the use of virus-inactivated blood products for patient with bleeding disorders, as well as changes of lifestyle among high risk groups."
Hmm, rates fell by 50%, and universal immunization did not happen in our state until 1995.
I wonder what states were immunizing all infants from 1987-1994?
"The rate was about four times greater in males than in females, and was also age dependent (low prevalence in children under 16 years of age, reaching a prevalence by 65 to 74 years of age of 7.0% in whites and 40% in African-Americans. Specific populations most likely to be infected are Asian-Pacific Islanders, Alaskan natives, and Asian-Americans. The Sentinel Counties Studies of the CDC have identified that, between the years 1992 and 1993, risk factors associated with reported cases were heterosexual exposure in 41%, drug abuse in 15%, homosexual activity in 9%, household contacts in 2%, health care employment in 1%, other rarer exposures in 1%, and unknown exposure in 31%."
http://www.hepnet.com/boca/seef2.html
************************************************** **********************
This was put together in 1998 so it's a bit out of date, but
it seems relevant. Note the large number of studies and case
reports in the "Central Nervous System DeMYELINation" section.
I guess case reports aren't evidence. Only poorly-constructed
epidemiological studies which don't have enough statistical
power to even theoretically demonstrate a risk are taken as
evidence by the IOM. -Dave
The IOM's latest report "Hepatitis B Vaccine and Demyelinating
Neurological Disorders" can be found here:
"
http://209.185.240.250/cgi-bin/linkrd?_lang=EN&lah=92c8dbd31a65deef1f1583f582e2a2 d9&lat=1024622468&hm___action=http%3a%2f%2fwww%2ei om%2eedu%2fIOM%2fIOMHome%2ensf%2fPages%2fhepatitis %2bb"
Abstracts on Hepatitis B Vaccine
"
http://209.185.240.250/cgi-bin/linkrd?_lang=EN&lah=9cc8c7b73705db3cc1abb7be0587f3 ae&lat=1024622468&hm___action=http%3a%2f%2fwww%2ew hale%2eto%2fv%2fmy8%2ehtml"
Dave Foster 1-12-98
Contents:
I. Overview
II. Central Nervous System Demyelination, Myelitis and Inflammation
III. Various Adverse Reactions: Mostly Case Reports
============
I. OVERVIEW
============
J Fam Pract 1997 Oct;45(4):295-315; quiz 317-8
Published erratum appears in J Fam Pract 1997 Dec;45(6):464
Hepatitis B virus infection, hepatitis B vaccine, and hepatitis B immune
globulin.
Zimmerman RK, Ruben FL, Ahwesh ER
Department of Family Medicine and Clinical Epidemiology, University of
Pittsburgh School of Medicine, USA.
Hepatitis B virus (HBV) infection is a major health problem in the United
States; in 1995, approximately 128,000 cases occurred. Transmission of HBV
occurs primarily by by blood exchange (eg, by shared needles during injection
drug use) and by sexual contact. Persons infected early in life are much
more likely to become chronically infected than those infected during
adulthood: as many as 90% of infants infected perinatally develop chronic
infection and up to 25% will die of HBV-related chronic liver disease as
adults. Clinical signs of acute hepatitis occur in about 50% of infected
adults but in only 5% of infected preschool-aged children. In the United
States, hepatitis B vaccine is currently made by recombinant DNA technology
using baker's yeast.
PMID: 9607051, UI: 98269934
Science 1998 Jul 31;281(5377):630-1
A shadow falls on hepatitis B vaccination effort.
Marshall E
PMID: 9714670, UI: 98370231
Lakartidningen 1996 Mar 6;93(10):883
[General vaccination against hepatitis B is not justified].
[Article in Swedish]
Oberg S
Infektionskliniken, Uddevalla sjukhus.
PMID: 8656789, UI: 96248664
Can Commun Dis Rep 1992 Apr 17;18(7):49-53
Adverse events following the administration of hepatitis B vaccines.
Bentsi-Enchill A
University of Ottawa.
PMID: 1291014, UI: 93177423
Vaccine 1993 Oct;11(13):1358-9
Serious hepatitis B vaccine adverse reactions, are they immune-mediated?
Carmeli Y, De-Medina T
Publication Types:
* Letter
PMID: 8296488, UI: 94127088
================================================== ===================
II. Central Nervous System Demyelination, Myelitis and Inflammation
================================================== ===================
Postgrad Med J 1997 Jul;73(861):462-3
Hepatitis B vaccine and neurotoxicity.
Pirmohamed M, Winstanley P
CSM Mersey Regional Monitoring Centre, Pharmacy Practice Unit, Liverpool,
UK.
PMID: 9338045, UI: 97479393
Lancet 1991 Nov 9;338(8776):1174-5
Central-nervous-system demyelination after immunisation with recombinant
hepatitis B vaccine.
Herroelen L, de Keyser J, Ebinger G
Department of Neurology, University Hospital, Free University of Brussels,
Belgium.
2 patients had neurological symptoms and signs, with evidence of
central-nervous-system demyelination, 6 weeks after administration of
recombinant hepatitis B vaccine. 1 had known multiple sclerosis but the
other had no history of neurological disease; both had HLA haplotypes DR2
and B7, which are associated with multiple sclerosis. A causal link between
vaccination and demyelination cannot be established from these 2
case-reports, but the time interval would fit a proposed immunological
mechanism.
Comments:
* Comment in: Lancet 1992 Jan 18;339(8786):178-9
PMID: 1682594, UI: 92047879
J Neurol Neurosurg Psychiatry 1995 Jun;58(6):758-9
Central nervous system demyelination after vaccination against hepatitis B
and HLA haplotype.
Kaplanski G, Retornaz F, Durand J, Soubeyrand J
Publication Types:
* Letter
PMID: 7608688, UI: 95332874
Neurology 1978 Sep;28(9 Pt 2):111-4
Viral models of demyelination.
Weiner LP, Stohlman SA
PMID: 568744, UI: 79053490
AJNR Am J Neuroradiol 1995 Mar;16(3):581-2
MR imaging in a case of postvaccination myelitis.
Tartaglino LM, Heiman-Patterson T, Friedman DP, Flanders AE
Department of Radiology, Jefferson Medical College, Philadelphia, Pa. 19107,
USA.
We describe a case of acute transverse myelitis after the administration of
the recombinant form of hepatitis B vaccine. Abnormal enhancement of MR
imaging accompanied residual neurologic deficit.
PMID: 7793384, UI: 95313683
Presse Med 1993 Dec 18;22(40):1997-8
[Acute myelitis after vaccination against hepatitis B].
[Article in French]
Mahassin F, Algayres JP, Valmary J, Bili H, Coutant G, Bequet D, Daly JP
Service de Clinique medicale, Hopital d'Instruction des Armees du
Val-de-Grace, Paris.
A 56-year old man was hospitalized for spasmodic paraparesis with sphincter
disorders. After exclusion of spinal cord compression and all other
inflammatory, infectious or neoplastic causes, the possibility of a
connexion with an hepatitis B vaccination performed with a recumbent vaccine
three weeks before the neurological disorders appeared was considered. The
pathogenesis of such a myelitis remains uncertain. It is based on the
possible reactivation of a dormant virus or a crossed antigenic reaction
between a protein of the vaccine and the nervous system. The course of the
disease is usually favourable. The frequency of this complication would be
more accurately determined if all neurological manifestations occurring
after hepatitis B vaccination were reported.
PMID: 8127802, UI: 94173824
J Korean Med Sci 1997 Jun;12(3):249-51
Acute Myelitis after hepatitis B vaccination.
Song HK, Kim HC, Yun YH
Department of Neurology, Hallym University Medical College, Kangdong Sacred
Heart Hospital, Seoul, Korea.
We report a case of myelitis after plasma-derived hepatitis B vaccination.
The patient was a 31-year-old man who presented with progressive sensory
symptoms in extremities that developed 2 weeks after a third vaccination.
MRI of the cervicothoracic region revealed swelling and T2 high signal at
the level of C4 to C5 cord, and isolated enhancement in the posterior
columns between C4 and C5 cord. The significance of MRI findings and HLA
haplotype of the patient will be briefly discussed.
PMID: 9250923, UI: 97394595
Gastroenterol Clin Biol 1996;20(4):401-2
[Acute myelitis after immunization against hepatitis B with recombinant
vaccine].
[Article in French]
Senejoux A, Roulot D, Belin C, Tsakiris L, Rautureau J, Coste T
Publication Types:
* Letter
PMID: 8758508, UI: 96332745
J Hepatol 1993 Sep;19(2):317-8
Transverse myelitis following hepatitis B vaccination.
Trevisani F, Gattinara GC, Caraceni P, Bernardi M, Albertoni F, D'Alessandro
R, Elia L, Gasbarrini G
Publication Types:
* Letter
PMID: 8301068, UI: 94132548
Presse Med 1997 Mar 8;26(7):328
[Acute aseptic meningitis after hepatitis B vaccination].
[Article in French]
Heinzlef O, Moguilewski A, Roullet E
Publication Types:
* Letter
PMID: 9122145, UI: 97252911
Presse Med 1996 Oct 26;25(32):1561-2
[Meningeal reaction after vaccination against hepatitis B].
[Article in French]
Marsaudon E, Barrault MF
Publication Types:
* Letter
PMID: 8952667, UI: 97110516
Am J Ophthalmol 1996 Sep;122(3):431-2
Multiple evanescent white dot syndrome after hepatitis B vaccine.
Baglivo E, Safran AB, Borruat FX
Department of Ophthalmology, Geneva University Hospital, Switzerland.
baglivo-edoardo@diogenes.hcuge.ch
PURPOSE: Hepatitis B vaccine has become an effective means of preventing
complications of hepatitis B. However, it occasionally induces serious side
effects. We report a case of multiple evanescent white dot syndrome (MEWDS)
that occurred following hepatitis B vaccination. METHODS: A 23-year-old
woman with a one-week history of progressive loss of vision in the left eye
and bilateral photopsia was referred for examination. Her symptoms appeared
24 hours after a booster intramuscular injection of hepatitis B vaccine.
RESULTS: Clinical examination, fluorescein angiography, and the course of
events were typical of MEWDS. CONCLUSIONS: This case demonstrates the
occasional occurrence of MEWDS after hepatitis B vaccine and suggests that
hepatitis B virus immunization may be a risk factor for this retinal
condition.
PMID: 8794720, UI: 96387180
Ann N Y Acad Sci 1997 Dec 29;830:319-21
Sudden hearing loss in childhood consequent to hepatitis B vaccination: a
case report.
Orlando MP, Masieri S, Pascarella MA, Ciofalo A, Filiaci F
ENT Clinic, University La Sapienza, Rome, Italy.
PMID: 9616691, UI: 98279663
Clin Infect Dis 1993 Nov;17(5):928-9
Multiple sclerosis and hepatitis B vaccination.
Nadler JP
Publication Types:
* Letter
PMID: 8286645, UI: 94114816
Acta Neurol Scand 1994 Jun;89(6):462-3
Acute cerebellar ataxia after immunisation with recombinant hepatitis B
vaccine.
Deisenhammer F, Pohl P, Bosch S, Schmidauer C
Department of Neurology, University of Innsbruck, Austria.
We report one woman with acute cerebellar ataxia (ACA), a well-defined
clinical syndrome, which occurred 10 days after the second vaccination with
recombinant hepatitis B vaccine. The patient had no previous symptoms or
signs of neurological disease and there was no evidence of neurologic
disease in the family history. Within nine months the symptoms remitted
completely according to other reports of ACA. As there was a close temporal
connection and no noticeable other cause we assume a causal link between the
vaccination and the disease. As far as we know this is the first case of
ACA after hepatitis B vaccination.
PMID: 7976236, UI: 95066735
Lancet 1993 Aug 28;342(8870):563-4
Visual loss and eosinophilia after recombinant hepatitis B vaccine.
Brezin A, Lautier-Frau M, Hamedani M, Rogeaux O, Hoang PL
Publication Types:
* Letter
Comments:
* Comment in: Lancet 1993 Oct 16;342(8877):998
PMID: 8102709, UI: 93360669
J Hepatol 1996 Jun;24(6):764-5
Leukoencephalitis after recombinant hepatitis B vaccine.
Manna R, De Santis A, Oliviero A, Carnevale A, Caputo S, Pahor M, Laudisio
A, Gasbarrini G
Publication Types:
* Letter
PMID: 8835755, UI: 96432703
================================================== ===
III. Various Adverse Reactions: Mostly Case Reports
================================================== ===
Arch Dis Child 1998 Mar;78(3):273-4
Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B
vaccine.
Ronchi F, Cecchi P, Falcioni F, Marsciani A, Minak G, Muratori G, Tazzari
PL, Beverini S
Divisione Pediatrica-Ospedale Civile di Cattolica (RN), Cattolica (RN),
Italy.
Three cases of immune thrombocytopenic purpura after the first dose of
recombinant hepatitis B vaccine occurred in infants under 6 months of age.
Other possible causes of this condition were excluded. Antiplatelet
antibodies were present. A defect in platelet production was excluded in two
children. Corticosteroid treatment was effective. Subsequent administration
of other vaccines (against polio, diphtheria, and tetanus) did not cause
relapse of thrombocytopenia.
PMID: 9613364, UI: 98276312
Eur J Dermatol 1998 Sep;8(6):435-6
Generalized granuloma annulare and hepatitis B vaccination.
Wolf F, Grezard P, Berard F, Clavel G, Perrot H
Dermatology Department, Hopital de l'Antiquaille, rue de l'Antiquaille,
69321 Lyon Cedex 05, France.
As hepatitis B vaccination is becoming generalized in Europe, cutaneous
adverse events are being more frequently reported in the literature. We
report the first case of generalized granuloma annulare following hepatitis
B immunization. A 51-year-old woman presented a generalized granuloma
annulare one month after the one-year booster injection of the hepatitis B
vaccine. The lesions resolved with sulfone therapy. We observed an identical
recurrence three weeks after the five-year booster.
PMID: 9729059, UI: 98398549
Lancet 1994 Nov 5;344(8932):1292-3
Liver dysfunction and DNA antibodies after hepatitis B vaccination.
Lilic D, Ghosh SK
Publication Types:
* Letter
PMID: 7967997, UI: 95057572
BMJ 1994 Dec 3;309(6967):1513
Reiter's syndrome attributed to hepatitis B immunisation.
Fraser PA, Wilson JD
Publication Types:
* Comment
* Letter
Comments:
* Comment on: BMJ 1994 Jul 9;309(6947):94
PMID: 7804068, UI: 95102375
Pediatr Dermatol 1994 Dec;11(4):363-4
Erythema multiforme following hepatitis B vaccine.
Di Lernia V, Lo Scocco G, Bisighini G
Publication Types:
* Letter
PMID: 7899194, UI: 95207066
Presse Med 1993 Feb 20;22(6):269
[Benign acute pericarditis after vaccination against hepatitis B].
[Article in French]
Bensaid J, Denis F
Publication Types:
* Letter
PMID: 8511146, UI: 93288675
N Engl J Med 1996 Aug 1;335(5):355
Cryoglobulinemia after hepatitis B vaccination.
Mathieu E, Fain O, Krivitzky A
Publication Types:
* Letter
PMID: 8668224, UI: 96283165
Presse Med 1997 Feb 1;26(2):75
[Erosive polyarthritis triggered by vaccination against hepatitis B].
[Article in French]
Soubrier M, Dubost JJ, Bielsa C, Ristori JM, Bussiere JL
Publication Types:
* Letter
PMID: 9082414, UI: 97226581
Med J Aust 1996 Feb 5;164(3):187
Hepatitis B surface antigenaemia in a child after vaccination.
Dickie AS, Olszewski EH
Publication Types:
* Letter
Comments:
* Comment in: Med J Aust 1996 Apr 15;164(8):510
PMID: 8628142, UI: 96205691
Lancet 1993 Oct 16;342(8877):998
Eosinophilia after intradermal hepatitis B vaccination.
Nagafuchi S, Tokiyama K, Kashiwagi S, Yayashi S, Imayama S, Niho Y
Publication Types:
* Comment
* Letter
Comments:
* Comment on: Lancet 1993 Aug 28;342(8870):563-4
PMID: 8105253, UI: 94018194
Ann Dermatol Venereol 1996;123(10):657-9
[Cutaneous lupus erythematosus and buccal aphthosis after hepatitis B
vaccination in a 6-year-old child].
[Article in French]
Grezard P, Chefai M, Philippot V, Perrot H, Faisant M
Service de Dermatologie, Hopital de l'Hotel-Dieu, Lyon.
INTRODUCTION: Although the hepatitis B vaccination tolerance is generally
good, adverse effects, which are specially neurologic and cutaneous, have
been observed and some cases of induced diseases with immunological
disorders have been reported. CASE REPORT: A 6 year-old boy presented a
cutaneous lupus erythematosus and a severe buccal aphthosis following
hepatitis B vaccination. There was no clinical or biological symptom of
systemic lupus erythematosus nor of Behcet's disease. Under chloroquine
therapy, the cutaneous manifestations of lupus erythematosus disappeared
quickly and those of buccal aphthosis improved. DISCUSSION: Hepatitis B
vaccination side effects are probably in relation with a specific or non
specific stimulation of the immune system. In our case, cellular immunity is
perhaps involved through the HBs antigen. Considering the rarity of these
side effects, an individual predisposition seems very likely.
PMID: 9615128, UI: 98277333
Arch Dermatol 1994 Oct;130(10):1329-30
Lichen planus following hepatitis B vaccination.
Aubin F, Angonin R, Humbert P, Agache P
Publication Types:
* Letter
PMID: 7944523, UI: 95031207
Am J Med 1995 Jun;98(6):595-6
A case of severe cytolysis after hepatitis B vaccination.
Germanaud J, Causse X, Trinh DH, Pfau-Fandard B, Trepo C
Publication Types:
* Comment
* Letter
Comments:
* Comment on: Am J Med 1992 Mar;92(3):254-6
PMID: 7778577, UI: 95297482
Presse Med 1996 Sep 28;25(28):1301
[Bilateral neuro-papillitis after hepatitis B vaccination].
[Article in French]
Berkman N, Benzarti T, Dhaoui R, Mouly P
Publication Types:
* Letter
PMID: 8949792, UI: 97107044
Rev Med Interne 1997;18(6):491-2
[Is hepatitis B vaccination a new cause of necrotizing vasculitis]?
[Article in French]
Kerleau JM, Levesque H, Lair G, Lecomte F, Carrara O, Courtois H
Publication Types:
* Letter
PMID: 9247052, UI: 97390000
Ann Rheum Dis 1998 Apr;57(4):256-7
A case of Churg-Strauss vasculitis after hepatitis B vaccination.
Vanoli M, Gambini D, Scorza R
Publication Types:
* Letter
PMID: 9709187, UI: 98374849
Presse Med 1997 Apr 26;26(14):670
[A case of segmentary unilateral occlusion of the central retinal vein
following hepatitis B vaccination].
[Article in French]
Berkman N
Publication Types:
* Letter
PMID: 9180888, UI: 97324783
Lancet 1996 Jun 8;347(9015):1626
Occlusion of central retinal vein after hepatitis B vaccination.
Devin F, Roques G, Disdier P, Rodor F, Weiller PJ
Publication Types:
* Letter
PMID: 8667894, UI: 96240964
Presse Med 1998 Jun 6;27(20):965-6
[Hypersensitivity vasculitis after hepatitis B vaccination].
[Article in French]
Masse I, Descoffres MC
Publication Types:
* Letter
PMID: 9767839, UI: 98440953
Thorax 1993 May;48(5):580-1
Pulmonary and cutaneous vasculitis following hepatitis B vaccination.
Allen MB, Cockwell P, Page RL
St James's University Hospital, Leeds.
PMID: 8322254, UI: 93310736
Endocr J 1998 Feb;45(1):135
Subacute thyroiditis after hepatitis B vaccination.
Toft J, Larsen S, Toft H
PMID: 9625459, UI: 98287141
Br J Rheumatol 1994 Oct;33(10):991
Acute sero-positive rheumatoid arthritis occurring after hepatitis
vaccination.
Vautier G, Carty JE
Publication Types:
* Letter
Scand J Rheumatol 1995;24(1):50-2
Arthritis after hepatitis B vaccination. Report of three cases.
Gross K, Combe C, Kruger K, Schattenkirchner M
Rheumatology Unit, LM University of Munich, Germany.
Side effects of hepatitis vaccination are rare. Only a few cases of
arthritis after hepatitis vaccination have been published. We report on
three cases of vaccination-induced arthritis with different resulting
disease. Two cases show the pattern of reactive arthritis. None of them was
associated with HLA-B27. In the third case onset of rheumatoid arthritis was
triggered by hepatitis vaccination. These three cases show that arthritis
after hepatitis B vaccination probably is more common than reported so far,
especially in a genetically predisposed subject (two of our patients
expressed HLA-DR4).
PMID: 7863281, UI: 95167436
Br J Rheumatol 1997 Feb;36(2):300-1
Polyarthritis associated with hepatitis B vaccination.
Bracci M, Zoppini A
Publication Types:
* Letter
PMID: 9133957, UI: 97279516
Clin Nephrol 1995 May;43(5):349
Nephrotic syndrome after recombinant hepatitis B vaccine.
Macario F, Freitas L, Correia J, Campos M, Marques A
Publication Types:
* Letter
PMID: 7634556, UI: 95361242
Clin Infect Dis 1992 Dec;15(6):1051
Evans's syndrome triggered by recombinant hepatitis B vaccine.
Martinez E, Domingo P
Publication Types:
* Letter
PMID: 1457642, UI: 93091042
************************************************** **********************
The development of rheumatoid arthritis after recombinant hepatitis B vaccination.
1: J Rheumatol 1998 Sep;25(9):1687-93 Comment in: * J Rheumatol. 1999 Jul;26(7):1636. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. Pope JE, Stevens A, Howson W, Bell DA. Department of Medicine, the University of Western Ontario, London, Canada. OBJECTIVE: Hepatitis B vaccination has been associated with reactive arthritis and rarely rheumatoid arthritis (RA). We defined the clinical, serologic, and immunogenetic background of patients developing RA, soon after recombinant hepatitis B vaccination.
10534549 [PubMed - indexed for MEDLINE] 1: Scand J Rheumatol 1995;24(1):50-2 Arthritis after hepatitis B vaccination. Report of three cases. Gross K, Combe C, Kruger K, Schattenkirchner M. Rheumatology Unit, LM University of Munich, Germany. Side effects of hepatitis vaccination are rare. Only a few cases of arthritis after hepatitis vaccination have been published. We report on three cases of vaccination-induced arthritis with different resulting disease. Two cases show the pattern of reactive arthritis. None of them was associated with HLA-B27. In the third case onset of rheumatoid arthritis was triggered by hepatitis vaccination. These three cases show that arthritis after hepatitis B vaccination probably is more common than reported so far, especially in a genetically predisposed subject (two of our patients expressed HLA-DR4). PMID: 7863281 [PubMed - indexed for MEDLINE] Rev Med Interne 1998 Feb;19(2):134-6 [Adult-onset Still's disease after hepatitis A and B vaccination?] [Article in French] Grasland A, Le Maitre F, Pouchot J, Hazera P, Bazin C, Vinceneux P. Service de medecine interne V, hopital Louis-Mourier, Colombes.
************************************************** *******
Hep B vax still has mercury!
Joint Statement Concerning Removal of Thimerosal from Vaccines
Approved on June 22, 2000
http://www.cdc.gov/nip/vacsafe/conce...atement_00.htm
Progress report on vaccine supply
During the year since the original statement, substantial progress has been made in removing thimerosal from vaccines. A hepatitis B vaccine without thimerosal produced by Merck Vaccine Division was released in August 1999, and in March 2000, a hepatitis B vaccine that does not contain thimerosal as a preservative was approved for SmithKline Beecham Biologicals. This SKBB product contains only a trace amount of mercury (less than 0.5mcg/dose), a greater than 96% reduction from the 12.5mcg in the previous SKBB vaccine and
an amount considered clinically insignificant. Maybe to them, not to me.
************************************************
http://www.massnews.com/past_issues/...01/701hep3.htm
Commissioner Koh's Testimony Was 'Wild'
By Ed Oliver
patriot76@net1plus.com
July 2001
Those in favor of ending mandatory hepatitis B vaccinations for Massachusetts' school children dispute the testimony given by Health Dept. Commissioner Howard Koh, M.D., last March when he opposed the bill.
************************************************** *
J Eur Acad Dermatol Venereol. 2004 Sep;18(5):603-606
http://www.ncbi.nlm.nih.gov/entrez/q..._uids=15324406
Two case reports of cutaneous adverse reactions following hepatitis B vaccine: lichen planus and granuloma annulare.
Criado P, De Oliveira Ramos R, Vasconcellos C, Jardim Criado R, Valente N.
Dermatology Unit, Allergy Unit, Estadual de Sao Paulo, Brazil.
************************************************** ****
DEFINITELY READ THIS!!!!
Congressional Hearing:
HEPATITIS B VACCINE: HELPING OR HURTING PUBLIC HEALTH?
http://frwebgate.access.gpo.gov/cgi-...d=f:63308.wais
************************************************** ******
Hep B cases reported 1997
http://www.cdc.gov/epo/mmwr/preview/...m#00003630.htm
************************************************** ****
:
You're fast! Then again, I was trying to NAK, and it always slows me down. 
